Amgen Kepivance To Launch In January; Additional Mucositis Trials Underway
Amgen will launch the oral mucositis treatment Kepivance (palifermin) in late January following FDA approval Dec. 15
Amgen will launch the oral mucositis treatment Kepivance (palifermin) in late January following FDA approval Dec. 15